Clinical Trial

Stone and Laser Therapies Post-Market Study (SALT)

Study acronym: SALT
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The objective of the SALT Study is to obtain post-market safety and device performance data for Boston Scientific's Stone and BPH study devices used during a diagnostic and/or therapeutic urinary tract procedure (e.g., transurethral or percutaneous access routes) or benign prostatic hyperplasia (BPH) treatment.
Protocol Amendment History 1 change
critical Enrollment closed, study ongoing 2026-08-13
Trial Details
NCT Number NCT06982235
Lead Sponsor Boston Scientific Corporation
Conditions Benign Prostate Hypertrophy(BPH), Renal Calculi, Ureteral Stones, Kidney Stones, Calculi, Urinary, Urinary Tract Procedure
Enrollment 238 participants
Start Date 2025-06-30
Primary Completion 2029-02 (estimated)
Study Completion 2029-02 (estimated)
Updated on ClinicalTrials.gov 2026-08-12